Despite initially being managed with standard of care using current T2DM guidelines, including the use of insulin therapy, this cohort had suboptimal control of their diabetes and Class 3 obesity before starting the LCD intervention. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.